BNCM some bigger boyz loading now 531k ask slap .01s $BNCM .0119 Huge BUYS, Remember $HIMS?
Delex Healthcare Group, Inc. is a Delaware-registered company specializing in #pharmaceutical and #medicaldevice distribution, primarily in the Philippines and Asia. It merged with Bounce Mobile Systems, Inc. (BNCM) in October 2024, operating through subsidiaries like Delex Pharma International, Inc., DLX Holdings, Inc., and JMN Brother’s Pharma Limited
????️ Projecting short-term price targets $0.15-$1.00
????️Financials (First 9 Months of 2025)Revenue: $7.974 million
Gross Profit: $4.84 million (60.7% margin)
Total Assets: $98.34 million (~$0.15 per share)
Audited by Ernst & Young.
????️Absolutely NO CONVERTIBLE DEBT, NO DILUTION
????️Operations
istributes 30+ #FDA-approved products to 900+ #pharmacies, 700+ hospitals, and 160 drug chains in the Philippines.Secured a $4.3 million contract in April 2025 for medical equipment supply to St. Irenaeus Medical Center.
????️Plans to expand to 60+ pharmacies by 2029 and integrate AI for ERP, EHR, and telemarketing.
????️ Strategic Moves:Targeting OTCQB uplisting in 2025, with NASDAQ plans and a potential ticker change to DELEX.
????️Partnerships with Philips, Masimo, and others drive medical device growth, expected to contribute 30% of revenue.
Merger with Bounce Mobile Systems, Inc. (BNCM):On July 2, 2024, Delex entered a reverse merger with Bounce Mobile Systems, Inc. (OTC: BNCM), completed by October 2024. The merger integrated Delex’s healthcare operations with BNCM’s platform, aiming to enhance market presence and operational efficiency.
????️Delex plans to uplist BNCM to #OTCQB in 2025 and #NASDAQ thereafter, with a potential ticker change to DELEX.
????️Product and Market Expansion:Launched 11 New #Pharmaceutical products in H1 2024, targeting #criticalcare, #oncology, and #anesthesia. Plans to introduce 11 more in 2025.
????️Secured a $4.3 million contract in April 2025 to supply #Philips diagnostic and interventional imaging systems (CT, MRI, Cath Lab) to St. Irenaeus Medical Center in Bulacan, Philippines.
????️Expanded medical device business through partnerships with U.S. and German companies, expected to contribute 30% of revenue.
????️Operates five brick-and-mortar pharmacies, with plans to expand to 60+ by 2029, leveraging the Philippines’ growing $130 billion medical device market.
????️Strategic Initiatives:#AI Integration: Plans to incorporate AI into #ERPsystems, #EHR, and #telemarketing to address inefficiencies in the $200 billion U.S. #healthcare administrative waste market.#ICU Forums: Reached nearly 200,000 #healthcare professionals globally by September 2024, boosting brand visibility.
????️Conventions and Outreach: Participated in six major conventions and 44 hybrid webinars in 2024 to engage healthcare professionals.
????️Partnership with Masimo: Distributes Masimo’s noninvasive monitoring technologies in the Philippines.
????️Philippines Healthcare Market: The medical device sector is projected to reach $2.3 billion by 2025, driven by hospital expansions and rising healthcare spending. Delex’s operations align with government initiatives like pharma-medical ecozones in Bulacan.
????️Critical Care Focus: Delex targets ICU needs with #FDA-approved drugs and devices, addressing gaps in critical care treatment.
????️Huge Partnerships with Amsino International, Verathon, Masimo Corporation, Philips Healthcare
#stocks #StockMarket #StockAlert
Delex Healthcare Group, Inc. is a Delaware-registered company specializing in #pharmaceutical and #medicaldevice distribution, primarily in the Philippines and Asia. It merged with Bounce Mobile Systems, Inc. (BNCM) in October 2024, operating through subsidiaries like Delex Pharma International, Inc., DLX Holdings, Inc., and JMN Brother’s Pharma Limited
????️ Projecting short-term price targets $0.15-$1.00
????️Financials (First 9 Months of 2025)Revenue: $7.974 million
Gross Profit: $4.84 million (60.7% margin)
Total Assets: $98.34 million (~$0.15 per share)
Audited by Ernst & Young.
????️Absolutely NO CONVERTIBLE DEBT, NO DILUTION
????️Operations
istributes 30+ #FDA-approved products to 900+ #pharmacies, 700+ hospitals, and 160 drug chains in the Philippines.Secured a $4.3 million contract in April 2025 for medical equipment supply to St. Irenaeus Medical Center. ????️Plans to expand to 60+ pharmacies by 2029 and integrate AI for ERP, EHR, and telemarketing.
????️ Strategic Moves:Targeting OTCQB uplisting in 2025, with NASDAQ plans and a potential ticker change to DELEX.
????️Partnerships with Philips, Masimo, and others drive medical device growth, expected to contribute 30% of revenue.
Merger with Bounce Mobile Systems, Inc. (BNCM):On July 2, 2024, Delex entered a reverse merger with Bounce Mobile Systems, Inc. (OTC: BNCM), completed by October 2024. The merger integrated Delex’s healthcare operations with BNCM’s platform, aiming to enhance market presence and operational efficiency.
????️Delex plans to uplist BNCM to #OTCQB in 2025 and #NASDAQ thereafter, with a potential ticker change to DELEX.
????️Product and Market Expansion:Launched 11 New #Pharmaceutical products in H1 2024, targeting #criticalcare, #oncology, and #anesthesia. Plans to introduce 11 more in 2025.
????️Secured a $4.3 million contract in April 2025 to supply #Philips diagnostic and interventional imaging systems (CT, MRI, Cath Lab) to St. Irenaeus Medical Center in Bulacan, Philippines.
????️Expanded medical device business through partnerships with U.S. and German companies, expected to contribute 30% of revenue.
????️Operates five brick-and-mortar pharmacies, with plans to expand to 60+ by 2029, leveraging the Philippines’ growing $130 billion medical device market.
????️Strategic Initiatives:#AI Integration: Plans to incorporate AI into #ERPsystems, #EHR, and #telemarketing to address inefficiencies in the $200 billion U.S. #healthcare administrative waste market.#ICU Forums: Reached nearly 200,000 #healthcare professionals globally by September 2024, boosting brand visibility.
????️Conventions and Outreach: Participated in six major conventions and 44 hybrid webinars in 2024 to engage healthcare professionals.
????️Partnership with Masimo: Distributes Masimo’s noninvasive monitoring technologies in the Philippines.
????️Philippines Healthcare Market: The medical device sector is projected to reach $2.3 billion by 2025, driven by hospital expansions and rising healthcare spending. Delex’s operations align with government initiatives like pharma-medical ecozones in Bulacan.
????️Critical Care Focus: Delex targets ICU needs with #FDA-approved drugs and devices, addressing gaps in critical care treatment.
????️Huge Partnerships with Amsino International, Verathon, Masimo Corporation, Philips Healthcare
#stocks #StockMarket #StockAlert
